Advanced Oncotherapy (LSE:AVO) Insider Ownership : 29.45 % (As of May. 15, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Advanced Oncotherapy Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Advanced Oncotherapy's insider ownership is 29.45%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Advanced Oncotherapy's Institutional Ownership is 2.36%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Advanced Oncotherapy's Float Percentage Of Total Shares Outstanding is 0.00%.

Advanced Oncotherapy Insider Ownership Historical Data

The historical data trend for Advanced Oncotherapy's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Oncotherapy Insider Ownership Chart

Advanced Oncotherapy Historical Data

The historical data trend for Advanced Oncotherapy can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Insider Ownership	29.45	29.45	29.45	29.45	29.45	29.45	29.45	29.45	29.45	29.45

Advanced Oncotherapy Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Advanced Oncotherapy (LSE:AVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (LSE:AVO) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Tenterden Street, Third Floor, London, GBR, W1S 1TE

Website

https://www.avoplc.com

Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.